Petrovax Pharm: The scientist-developer of the enzyme replacement therapy for Fabry disease from the USA highly appreciated the Russian bioanalogue Fabagal

Press/Media

Period20 May 2025

Media coverage

1

Media coverage

  • TitlePetrovax Pharm: The scientist-developer of the enzyme replacement therapy for Fabry disease from the USA highly appreciated the Russian bioanalogue Fabagal
    Media name/outletRussia Business News
    Date20/05/25
    PersonsRobert Desnick, Melissa Wasserstein
View all 1
View less

Related content